IBU-tec advanced materials AG

  • WKN: A0XYHT
  • ISIN: DE000A0XYHT5
  • Land: Deutschland

Nachricht vom 14.06.2021 | 08:30

IBU-tec advanced materials AG enters into extensive sales cooperation for battery materials with globally operating Asian group

DGAP-News: IBU-tec advanced materials AG / Key word(s): Miscellaneous
14.06.2021 / 08:30
The issuer is solely responsible for the content of this announcement.

 

IBU-tec advanced materials AG enters into extensive sales cooperation for battery materials with globally operating Asian group

- Stepped-up penetration of the Asian market and extension of the battery business in line with strategy

- Sales partner of IBU-tec is one of the worldwide leading suppliers in the field of battery materials for electromobility, amongst others

- IBU-tec will begin to build up stock with own battery product to satisfy the anticipated high demand


Weimar, 14 June 2021 - IBU-tec advanced materials AG ("IBU-tec", ISIN: DE000A0XYHT5) has entered into an extensive sales cooperation with a globally operating Asian group for the current battery material of IBU-tec and future products. This represents an important achievement for IBU-tec with a view to the stepped-up penetration of the Asian market and the expansion of the battery business. The distribution partner is one of the worldwide leading suppliers in the field of battery materials, which are used, for instance, in batteries for electromobility. The battery material from IBU-tec stands out with its high quality and efficiency. The fields of application of the current product include LFP battery cells, which are used, for instance, for e-mobility and stationary energy storage systems. It will be available on the global markets from the beginning of the fourth quarter 2021.

Due to the large potential of the sales cooperation and the already high interest in the battery product, IBU-tec will begin to manufacture for stock, and will expand the corresponding stocking until the end of the year.

Ulrich Weitz, CEO, IBU-tec advanced materials AG: "The fact that we have been able to enter into a sales agreement for our battery product with one of the leading global suppliers of cathode materials even before the official market launch, is a milestone for our company. This shows that we perfectly meet the market demand with our efficient and high-quality product. Moreover, we continue to work full speed within the framework of research projects on the development of further high-quality battery materials."

About IBU-tec

The IBU-tec Group develops and produces innovative materials of the highest quality for the industry. It combines unique, partly patent-protected thermal process engineering, with the process and material know-how of around 250 highly qualified employees. The products include important components of battery materials for electric mobility and stationary energy storage, as well as solutions for air purification, resource conservation or the reduction of plastic packaging. IBU-tec is thus in a long-term position to respond to global mega trends, especially in the fields of climate and environmental protection. It has an international customer base ranging from innovative medium-sized companies to global corporations.
Further information can be found online at www.ibu-tec.de.

Contact

edicto GmbH
Axel Mühlhaus
Eschersheimer Landstraße 42-44
60322 Frankfurt
Tel. +49 (0) 69-905505-52
Email: IBU-tec@edicto.de



14.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

FORTEC Elektronik Aktiengesellschaft

Original-Research: FORTEC Elektronik AG (von Montega AG): Kaufen

29. November 2021